Evidence map›Paper›PMID 42615604›Full record

ArticleMicrobiology spectrum2026

Systems-level insights into age-dependent innate immune responses in influenza B infection.

Shikha Saxena, Gurleen Kaur, Preeti Vishwakarma, Varun Kumar, Amit Kumar, Sonia Ompal, Satish Kumar, Sarjeet Singh, Akanksha Chauhan, Susmita Chaudhuri and 2 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shikha Saxena *Center for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.ORCID 0000-0003-3895-4494
Gurleen Kaur *Center for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.ORCID 0009-0002-9867-7847
Preeti VishwakarmaCenter for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.
Varun KumarCenter for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.
Amit KumarCenter for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.
Sonia OmpalCenter for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.
Satish KumarCenter for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.
Sarjeet SinghCenter for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.
Akanksha ChauhanCenter for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.
Susmita ChaudhuriCenter for Microbial Research, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.ORCID 0000-0002-2558-4933
Waseem Akram MallaICMR-National Institute of Malaria Research Field Unit, Guwahati, Assam, India.ORCID 0000-0002-9505-8648
Sweety SamalCenter for Virus Research, Therapeutics and Vaccines, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.ORCID 0000-0001-7894-8756

Funding

Department of Biotechnology, Ministry of Science and Technology, India H2020-SC1-2019-874650-ENDFLUDepartment of Biotechnology, Ministry of Science and Technology, India H2020-SC1-2019-874653-INDIGO
6 · The paper itself

Abstract

Aging is known to alter innate immune function, increasing susceptibility to viral infections, yet its specific effects on influenza B virus (IBV) infection remain poorly characterized. To address this gap, we developed a preclinical mouse model using a clinically relevant IBV strain Inf B/Phuket/3073/2013 to compare innate immune responses between young adult and aged mice, with a particular focus on age-related transcriptional and proteomic alterations in lung during infection. Bulk RNA sequencing and proteomics analysis of lung tissue harvested post-infection revealed distinct age-dependent transcriptional profiles. Bulk RNA-seq analysis identified 1,350 differentially expressed genes (DEGs), of which 824 exhibited an aged-biased expression pattern and were significantly upregulated in the lungs of influenza B virus-infected aged mice. Functional enrichment of these DEGs indicated perturbations in innate immune signaling, apoptosis, and pathways related to cellular stress and DNA damage in aged mice. There are several differentially expressed proteins that have been identified in young adult and aged influenza B infection. Among these differentially expressed proteins, some commonly co-expressed proteins have a role in virus entry, signaling pathways, and interferon response. Real-time PCR analysis confirmed altered expression of key innate immune genes, including Toll-like receptors (TLRs), interferon regulatory factors (IRF7 and IRF9), key antiviral genes (IFIT -2, IFIT-3 and STAT-1) and type I and II interferons (IFN-α, IFN-β, IFN-γ). Notably, young adult mice exhibited a more coordinated and robust activation of antiviral pathways, whereas aged mice demonstrated delayed and aberrant immune responses, characterized by excessive inflammation and impaired interferon signaling. IMPORTANCE: This study provides a comprehensive system-level analysis of age-driven alterations in innate immunity during influenza B virus (IBV) infection. While prior evidence has established that aging impairs antiviral responses across various viral infections, our findings specifically demonstrate that IBV infection in aged mice leads to a disproportionate and dysregulated transcriptional activation of innate immune pathways, including excessive type I interferon signaling and altered inflammatory mediator profiles, and uncover the potential therapeutic targets to improve health outcomes in the elderly population on influenza infection.

Indexed as

AgingImmunity, InnateInfluenza B virusInfluenza, HumanOrthomyxoviridae InfectionsAge FactorsAnimalsDisease Models, AnimalFemaleGene Expression ProfilingHumansInterferon Regulatory Factor-7LungMiceProteomicsSignal TransductionInterferon Regulatory Factor-7agingbulk RNA sequencingimmune responsesinfluenza Binterferontoll-like receptors

Identifiers

PMID42615604
PMCPMC13688880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.